Literature DB >> 8614042

Interleukin-10 is associated with the development of sepsis in trauma patients.

R M Sherry1, J I Cue, J K Goddard, J B Parramore, J T DiPiro.   

Abstract

Interleukin-10 (IL-10) is a potent regulator of proinflammatory cytokines, including tumor necrosis factor-alpha, IL-1, IL-6, and interferon-gamma. We retrospectively evaluated 66 severely injured patients for detectable plasma IL-10. the presence or absence of IL-10 was correlated with clinical parameters. Forty of 66 patients had detectable levels of IL-10. Plasma IL-10 was associated with admission hypotension (p < 0.01) and the development of sepsis (p < 0.05). There was no difference between IL-10-positive and -negative patients with respect to age, mechanism or severity of injury, blood transfusion, operative interventions, or the subsequent development of ARDS, hepatic dysfunction, or renal insufficiency. We conclude that IL-10 can be detected in the plasma of some severely injured patients and that it is associated with the development of sepsis. Further investigation of the immunoregulatory effects of IL-10 after trauma is indicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614042     DOI: 10.1097/00005373-199604000-00016

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  32 in total

1.  [Clinical course and prognostic significance of immunological and functional parameters after severe trauma].

Authors:  S Lendemans; E Kreuzfelder; C Waydhas; D Nast-Kolb; S Flohé
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

2.  Minimally invasive video-assisted versus conventional open thyroidectomy on immune response: a meta analysis.

Authors:  Chenhong Zheng; Shouying Liu; Peiliang Geng; Huiming Zhang; Hongpeng Zhang; Airong Tang; Xiaohua Xie
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

Review 4.  Transfusion-associated microchimerism: the hybrid within.

Authors:  Evan M Bloch; Rachael P Jackman; Tzong-Hae Lee; Michael P Busch
Journal:  Transfus Med Rev       Date:  2012-10-24

5.  Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells.

Authors:  Roop Gill; Xiangcai Ruan; Christoph L Menzel; Seung Namkoong; Patricia Loughran; David J Hackam; Timothy R Billiar
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

6.  Development of a murine model of blunt hepatic trauma.

Authors:  Jean A Nemzek-Hamlin; Haejin Hwang; Joseph A Hampel; Bi Yu; Krishnan Raghavendran
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

7.  Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Authors:  Alaka Mullick; Miria Elias; Serge Picard; Lucie Bourget; Orce Jovcevski; Susan Gauthier; Ashleigh Tuite; Penelope Harakidas; Craig Bihun; Bernard Massie; Philippe Gros
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults.

Authors:  Katherine A Barsness; Denis D Bensard; David A Partrick; Casey M Calkins; Richard J Hendrickson; Anirban Banerjee; Robert C McIntyre
Journal:  Pediatr Surg Int       Date:  2004-04-21       Impact factor: 1.827

9.  Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients.

Authors:  Thomas Murphy; Hugh Paterson; Selwyn Rogers; John A Mannick; James A Lederer
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

10.  Predictive value of cytokines for developing complications after polytrauma.

Authors:  Anne-Britt E Dekker; Pieta Krijnen; Inger B Schipper
Journal:  World J Crit Care Med       Date:  2016-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.